
Search
Filter Results
Displaying 31–40 of 526 for “Retinitis pigmentosa”
-
Oct 1, 2025
Foundation Fighting Blindness Celebrates Blindness Awareness Month with #ShareYourVision Campaign
This social media campaign amplifies authentic stories from the blind and low vision community to highlight the spectrum of vision loss experiences.
-
Sep 25, 2025
Foundation Fighting Blindness Announces Over $9 Million in New Research Awards for FY2025
The Foundation Fighting Blindness is proud to announce the funding of 16 innovative research projects in Fiscal Year 2025, totaling over $9 million in new grants.
-
Jul 2, 2025
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
May 30, 2025
Legacy Donor Spotlight: Dr. Debora Elliott Ward
Dr. Debora Elliott Ward, a clinical psychologist living with retinitis pigmentosa, shares her journey of resilience, professional success, and commitment to supporting the Foundation Fighting Blindness by naming it a beneficiary in her estate plans.
-
May 29, 2025
I find it difficult to explain my eyesight to people. I have retinitis pigmentosa (RP), which is a condition that progressively causes vision loss. I am legally blind, my peripheral vision is very limited, and most of what I see is blurry.
-
Nov 14, 2024
Strengthening research in retinal disease with record-breaking $19.8 million investment in innovative projects targeting vision loss worldwide.
-
Sep 16, 2024
Foundation Fighting Blindness Hosts Chicago Night for Sight Event
The October 5th event will raise awareness and fund research driving treatments and cures for blinding diseases and macular degeneration.
-
Sep 7, 2023
Foundation Funds 25 New Grants Totaling $15.1 Million in FY23
The global leader in retinal degenerative disease research supports a total of 93 research grants in its portfolio.
-
Oct 10, 2022
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Reports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
Jul 25, 2022
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases